This trial was conducted in Europe, Middle East, North America and South America. The aim of this trial was to compare the use of an intensified insulin treatment with insulin aspart (NovoRapid®) versus human insulin (Actrapid®) in pregnancy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
419
Relative risk of major maternal hypoglycaemia
Time frame: after 24 hours
Relative risk of major and minor hypoglycaemia
Diabetic complications
Obstetric complications
Other Adverse Events
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Novo Nordisk Investigational Site
Ciudad de Buenos Aires, Argentina
Novo Nordisk Investigational Site
Pcia de Cordoba, Argentina
Novo Nordisk Investigational Site
Graz, Austria
Novo Nordisk Investigational Site
Salzburg, Austria
Novo Nordisk Investigational Site
Vienna, Austria
Novo Nordisk Investigational Site
Vienna, Austria
Novo Nordisk Investigational Site
Sofia, Bulgaria
Novo Nordisk Investigational Site
Halifax, Nova Scotia, Canada
Novo Nordisk Investigational Site
Ottawa, Canada
Novo Nordisk Investigational Site
St. John's, Canada
...and 85 more locations